Genetic aspects of hypertensive effect of lead;Genetyczne aspekty hipertensyjnego dziaŁania oŁowiu

Medycyna Pracy

Volumn 59, Issue 4, 2008, Pages 325-332

  Skoczyńska, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Arterial hypertension; Genetic polymorphisms; Lead

Indexed keywords

CHEMICALLY INDUCED DISORDER; ENVIRONMENTAL EXPOSURE; GENETIC POLYMORPHISM; GENETICS; HUMAN; HYPERTENSION; LEAD POISONING; OCCUPATIONAL EXPOSURE; POLLUTANT; REVIEW;

ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS; HYPERTENSION; LEAD POISONING; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC;

EID: 57149112763     PISSN: 04655893     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Victery W.: Evidence for effects of chronic lead exposure on blood pressure in experimental animals: an overview. Environ. Health Perspect. 1988;78:71-76
2. Puri V.N.: Acute effects of cadmium on the renin angiotensin system in rats. Biochem. Pharmacol. 1992;44(1): 187-188
3. Skoczyńska A.: Ołów jako czynnik ryzyka chorób układu krażenia. Górnicki Wydawnictwo Medyczne, Wrocław 2006
4. Pirkle J.L., Schwartz J., Landis J.R., Harlan W.R.: The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am. J. Epidemiol. 1985;121(2):246-258
5. Harlan W.R.: The relationship of blood lead levels to blood pressure in the US population. Environ. Health Perspect. 1988;78:9-13
6. Landis J.R., Flegal K.M.: Generalized Mantel-Haenszel analysis of the regression of blood pressure on blood lead using NHANES II data. Environ. Health Perspect. 1988; 78:35-41
7. Apostoli P., Maranelli G., Dei-Gas L., Micciolo R.: Blood lead and blood pressure: a cross sectional study in a general population group. Cardiologia 1990;35(7):597-603
8. Schwartz J.: Lead, blood pressure, and cardiovascular disease in men and women. Environ. Health Perspect. 1991;91:71-75
9. Morisi G., Menditto A., Spagnolo A., Patriarca M., Menotti A.: Association of selected social, environmental and constitutional factors to blood lead levels in men aged 55-75 years. Sci. Total Environ. 1992;126(3):209-229
10. Menditto A., Morisi G., Spagnolo A., Menotti A.: Association of blood lead to blood pressure in men aged 55 to 75 years: effect of selected social and biochemical confounders. NRF Study Group. Environ. Health Perspect. 1994;102(Supl. 9):107-111
11. Bost L., Primatesta P., Dong W., Poulter N.: Blood lead and blood pressure: evidence from the Health Survey for England 1995. J. Hum. Hypertens. 1999;13(2):123-128
12. Hu H., Aro A., Payton M. Korrick S., Sparrow D., Weiss S.T. i wsp.: The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA 1996;275(15):1171-1176
13. Nash D., Magder L., Lustberg M., Sherwin R.W., Rubin R.J., Kaufmann R.B. i wsp.: Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA 2003 26;289(12):1523-1532
14. Vupputuri S., He J., Muntner P., Bazzano L.A., Whelton P.K., Batuman V.: Blood lead level is associated with elevated blood pressure in blacks. Hypertension 2003; 41:463-468
15. Magri J., Sammut M., Savona-Ventura C.: Lead and other metals in gesttional hypertension. Int. J. Gynaecol. Obstet. 2003;83(1):29-36
16. Staessen J.A., Bulpitt C.J., Fagard R., Lauwerys R.R., Roels H., Thijs L.i wsp.: Hypertension caused by low-level lead exposure: myth or fact? J. Cardiovasc. Risk 1994;1 (1):87-97
17. Staessen J.: Low-level lead exposure, renal function and blood pressure. Verh. K. Acad. Geneeskd. Belg. 1995;57(6):527-574
18. Staessen J.A., Roels H., Lauwerys R.R., Amery A. Low-level lead exposure and blood pressure. J. Hum. Hypertens. 1995;9(5):303-328
19. Nawrot T.S., Thijs L., den Hond E.M., Roels H.A., Staessen J.A.: An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J. Hum. Hypertens. 2002;16(2):123-131
20. Martin D., Glass T.A., Bandeen-Roche K., Todd A.C., Shi W., Schwartz B.S.: Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. Am. J. Epidemiol. 2006;163: 467-478
21. Sakai T., Morita Y., Araki T., Kano M., Yoshida T.: Relationship between delta-aminolevulinic acid dehydratase genotypes and heme precursors in lead workers. Am. J. Ind. Med. 2000; 38(3):355-360
22. Wetmur J.G., Kaya A.H., Plewinzka M., Desnick R.J.: Molecular characterization the human δ-aminolevulinate dehydratase 2 (ALAD 2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am. J. Hum. Genet. 1991;49:757-763
23. Kelada S.N., Shelton E., Kaufmann R.B., Khoury M.J.: δ- Aminolevulinic acid dehydratase genotype and lead toxicity: A huGE review. Am. J. Epidemiol. 2001;154:1-13
24. Scinicariello F., Murray H.E., Moffett D.B., Abadin H.G., Sexton M.J., Fowler B.A.: Lead and δ-aminolevulinic acid dehydratase polymorphism: Where does it lead? A meta-analysis. Environ. Health Perspect. 2007;115(1):35-41
25. Süzen H.S., Duydu Y., Aydin A., Işimer A., Vural N.: Influence of the delta-aminolewulinic acid dehydratase (ALAD) polymorphism on biomarkers of lead exposure in Turkish storage battery manufacturing workers. Am. J. Ind. Med. 2003;43(2):165-171
26. Montenegro M.F., Barbosa F.J., Sandrim V.C., Gerlach R.F., Tanus-Santos J.E.: A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio. Arch. Toxicol. 2006;80(7):394-398
27. Duydu Y., Süzen H.S.: Influence of delta-aminolevulinic acid dehydratase (ALAD) polymorphism on the frequency of sister chromatid exchange (SCE) and the number of high-frequency cells (HFCs) in lymphocytes from lead-exposed workers. Mutat. Res. 2003;540(1):79-88
28. Duydu Y., Dur A., Süzen H.S. Evaluation of increased proportion of cells with unusually high sister chromatid exchange counts as a cytogenetic biomarker for lead exposure. Biol. Trace Elem. Res. 2005;104(2):121-129
29. Duydu Y., Süzen H.S., Aydin A., Cander O., Uysal H., Isimer A. i wsp.: Correlation between lead exposure indicators and sister chromatid exchange (SCE) frequencies in lymphocytes from inorganic lead exposed workers. Arch. Environ. Contam. Toxicol 2001;41(2):241-246
30. Wu F.Y., Chang P.W., Wu C.C., Lai J.S., Kuo H.W.: Lack of association of delta-aminolevulinic acid dehydratase genotype with cytogenetic damage in lead workers. Int. Arch. Occup. Environ. Health 2004;77(6):395-400
31. Alexander B.H., Checkoway H., Costa-Mallen P., Faustman E.M., Woods J.S., Kelsey K.T. i wsp.: Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. Environ. Health Perspect. 1998;106(4):213-216
32. Agerholm-Larsen B., Nordestgaard B.G., Tybjærg-Hansen A.: ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler. Thromb. Vasc. Biol. 2000;20(2):484-492
33. Van Rijn M.J.E., Bos M.J., Yazdanpanah M., Isaacs A., Arias-Vásquez A., Koudstaal P.J. i wsp.: α-Adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular risk. Stroke 2006;37:2930-2934. DOI: 10.1161/01.STR.0000248760.67039.2b
34. Balkestein E.J., Wang J.G., Struijker-Boudier H.A., Barlassina C., Bianchi G., Birkenhäger W.H. i wsp.: Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian population. J. Hypertens. 2002;20(8):1551-1561
35. Ferdinand K.C., Armani A.M.: The management of hypertension in African Americans. Crit. Pathw. Cardiol. 2007;6(2):67-71
36. Hindorff L.A., Heckbert S.R., Psaty B.M., Lumley T., Siscovick D.S., Herrington D.M. i wsp.: beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study. Am. J. Hypertens. 2005;18(3):392-397
37. Snieder H., Dong Y., Barbeau P., Harshfield G.A., Dalageogou C., Zhu H. i wsp.: Beta2-adrenergic receptor gene and resting hemodynamics in European and African American youth. Am. J. Hypertens. 2002;15(11):973-979
38. Schelleman H., Klungel O.H., Witteman J.C., Hofman A., van Duijn C.M., de Boer A. i wsp.: The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure. Eur. J. Hum. Genet. 2006;14(7): 860-866
39. Schelleman H., Stricker B.H., Verschuren W.M., de Boer A., Kroon A.A., de Leeuw P.W. i wsp.: Interactions between five candidate genes and antihypertensive drug therapy on blood pressure. Pharmacogenomics J. 2006;6(1):22-26
40. Weaver V.M., Schwartz B.S., Ahn K.D., Stewart W.F., Kelsey K.T., Todd A.C. i wsp.: Associations of renal function with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ. Health Perspect. 2003;111(13):1613-1619
41. Weaver V.M., Lee B.K., Todd A.C., Ahn K.D., Shi W., Jaar B.G. i wsp.: Effect modification by dela-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase gene polymorphisms on associations between patella lead and renal function in lead workers. Environ. Res. 2006;102(1):61-69
42. Lustberg M.E., Schwartz B.S., Lee B.K., Todd A.C., Silbergeld E.K.: The G(894)-T(894) polymorphism in the gene for endothelial nitric oxide synthase and blood pressure in lead-exposed workers from Korea. J. Occup. Environ. Med. 2004;46(6):584-590
43. Lee B.K., Lee G.S., Stewart W.F., Ahn K.D., Simon D., Kelsey K.T. i wsp.: Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ. Health Perspect. 2001:109(4):383-389
44. Bertel O., Bühler ER., Ott J.: Lead-induced hypertension: blunted beta adrenoceptor-mediated functions. Br. Med. J. 1978;1:551-553
45. Skoczynska A., Juzwa W., Smolik R., Szechiński J., Běhal F.J.: Response of the cardiovascular system to catecholamines in rats given small doses of lead. Toxicology 1986;39(3):275-289
46. Skoczyńska A., Wróbel J., Andrzejak R.: Lead-cadmium interaction effect on the responsiveness of rat mesenteric vessels to norepinephrine and angiotensin II. Toxicology 2001;162(3):157-170
47. Chang H.R., Tsao D.A., Yu H.S., Ho C.K.: The change of beta-adrenergic system after cessation of lead exposure. Toxicology 2005;207(1):73-80
48. Barbosa F. Jr., Sertorio J.T., Gerlach R.F., Tanus-Santos J.E.: Clinical evidence for lead-induced inhibition of nitric oxide formation. Arch. Toxicol. 2006;80(12):811-816